These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 17026484)

  • 41. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome.
    Bugger H; Abel ED
    Clin Sci (Lond); 2008 Feb; 114(3):195-210. PubMed ID: 18184113
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.
    Vona-Davis L; Howard-McNatt M; Rose DP
    Obes Rev; 2007 Sep; 8(5):395-408. PubMed ID: 17716297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.
    Sarzani R; Salvi F; Dessì-Fulgheri P; Rappelli A
    J Hypertens; 2008 May; 26(5):831-43. PubMed ID: 18398321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Syndrome X and general medicine].
    Guillaume G; Moinie S; Bauler A
    Rev Med Brux; 1995; 16(2):79-82. PubMed ID: 7784742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathogenesis and etiology of essential hypertension: role of dietary carbohydrate.
    Kopp W
    Med Hypotheses; 2005; 64(4):782-7. PubMed ID: 15694697
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sleep and the metabolic syndrome.
    Wolk R; Somers VK
    Exp Physiol; 2007 Jan; 92(1):67-78. PubMed ID: 17085678
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Leptin and insulin action in severely obese women.
    Papadia F; Marinari GM; Camerini G; Civalleri D; Scopinaro N; Adami GF
    Obes Surg; 2003 Apr; 13(2):241-4. PubMed ID: 12740131
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function].
    Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M
    Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome.
    Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):473-81. PubMed ID: 17451923
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular mechanisms of insulin resistance and associated diseases.
    Mlinar B; Marc J; Janez A; Pfeifer M
    Clin Chim Acta; 2007 Jan; 375(1-2):20-35. PubMed ID: 16956601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of leptin in blood pressure regulation and arterial hypertension.
    Bełtowski J
    J Hypertens; 2006 May; 24(5):789-801. PubMed ID: 16612235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leptin and cardiovascular diseases.
    Luo JD; Zhang GS; Chen MS
    Drug News Perspect; 2005 Sep; 18(7):427-31. PubMed ID: 16362081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
    Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
    Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice.
    Karagiannides I; Abdou R; Tzortzopoulou A; Voshol PJ; Kypreos KE
    FEBS J; 2008 Oct; 275(19):4796-809. PubMed ID: 18754772
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular mechanisms for vascular injury in the metabolic syndrome.
    Yamagishi S; Nakamura K; Jinnouchi Y; Takenaka K; Imaizumi T
    Drugs Exp Clin Res; 2005; 31(3):123-9. PubMed ID: 16033251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications.
    Savoia C; Volpe M; Alonzo A; Rossi C; Rubattu S
    Clin Sci (Lond); 2009 Nov; 118(4):231-40. PubMed ID: 19886866
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Insulin resistance syndrome and hypertension].
    Shimamoto K
    Hokkaido Igaku Zasshi; 2000 Jan; 75(1):9-14. PubMed ID: 10736756
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of stress in the pathogenesis of the metabolic syndrome.
    Rosmond R
    Psychoneuroendocrinology; 2005 Jan; 30(1):1-10. PubMed ID: 15358437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.